Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02835521Phase 4Unknown
Phase 4, randomised, single-blind trial (2 arms), sponsored by Federal University of São Paulo. Primary endpoint: Change on pain at 12 weeks. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02835521.